Table 4 Comparison of the IHC4+C score with the NPI in assessing risk of breast cancer distant recurrence

From: Assessment of the contribution of the IHC4+C score to decision making in clinical practice in early breast cancer

 

IHC4-C

 

Low, 0–10.0%

Intermediate, >10.0–20.0%

High, >20.0%

NPI

 Low (<3.4)

35

3

0

 Intermediate (3.4–5.4)

24

22

13

 High (>5.4)

0

0

4

  1. Agreement: 60.4% (95% CI: 50.2–70.0), P<0.001.
Back to article page